Provocative results' boost hopes of antibody treatment for COVID-19 | Science | AAAS
Eli Lilly's Antibody Treatment Gets Emergency F.D.A. Approval - The New York Times
Antibody drug may cut Covid-19 hospitalizations, company says
Eli Lilly reports positive phase 3 trial results for Covid antibody drug
Eli Lilly says its antibody therapy helps prevent Covid-19 in nursing homes | CNN
First Antibody Trial Launched in COVID-19 Patients | The Scientist Magazine®
FDA revises Lilly's COVID-19 antibody combo EUA for use after exposure to virus | Reuters
Eli Lilly teams up with pharma rival GSK and partner Vir for COVID-19 antibody test | Fierce Biotech
Eli Lilly rushes to FDA with its COVID-19 antibody for emergency green light, reveals new cocktail therapy data | Fierce Biotech
Neutralizing monoclonal antibodies for treatment of COVID-19 | Nature Reviews Immunology
Lab tests: Eli Lilly, Regeneron antibody therapies lose out against Omicron | Reuters
Antibody treatments going unused in Washington state – KIRO 7 News Seattle
Eli Lilly, Regeneron Report More Positive Data on Covid-19 Antibody Cocktails - Barrons
Eli Lilly gets DCGI emergency use approval for COVID-19 antibody cocktail drug
Eli Lilly says its monoclonal antibody cocktail is effective against Covid-19
GlaxoSmithKline (GSK), Eli Lilly (LLY) Join to Test Covid-19 Antibody Cocktail - Bloomberg
How monoclonal antibodies work against omicron variant - ABC News
Development and application of therapeutic antibodies against COVID-19
U.S. limits supply of Eli Lilly's Covid-19 antibody therapy in 3 states
Timely treatment with COVID-19 monoclonal antibodies can reduce hospitalizations, pandemic's stress on health care systems - USF Health NewsUSF Health News
Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies - eBioMedicine
Lilly: Maximizing manufacturing capacity is key to COVID-19 antibody strategy
Regeneron submits request for EUA for COVID-19 antibody cocktail
